HPL Stock Overview
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Hoechst Pakistan Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨3,250.00 |
| 52 Week High | PK₨3,480.00 |
| 52 Week Low | PK₨1,210.01 |
| Beta | 0.17 |
| 1 Month Change | 8.37% |
| 3 Month Change | 18.18% |
| 1 Year Change | 140.05% |
| 3 Year Change | 265.17% |
| 5 Year Change | 351.39% |
| Change since IPO | 2,395.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| HPL | PK Pharmaceuticals | PK Market | |
|---|---|---|---|
| 7D | 1.8% | 1.1% | 1.9% |
| 1Y | 140.1% | 163.4% | 57.8% |
Return vs Industry: HPL underperformed the PK Pharmaceuticals industry which returned 163.4% over the past year.
Return vs Market: HPL exceeded the PK Market which returned 58% over the past year.
Price Volatility
| HPL volatility | |
|---|---|
| HPL Average Weekly Movement | 6.0% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in PK Market | 8.2% |
| 10% least volatile stocks in PK Market | 3.4% |
Stable Share Price: HPL has not had significant price volatility in the past 3 months compared to the PK market.
Volatility Over Time: HPL's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 734 | Sajjad Iftikhar | www.hoechst.com.pk |
Hoechst Pakistan Limited engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally. The company provides its antibiotic, cardiology, diabetes, pain and allergy, and other products under Flagyl, Clexane, NO-SPA, Lantus, Amaryl, Claforan, Haemaccel, Enterogermina, and Plavix brands. It also offers various shampoos under the Selsun Blue brand name.
Hoechst Pakistan Limited Fundamentals Summary
| HPL fundamental statistics | |
|---|---|
| Market cap | PK₨31.35b |
| Earnings (TTM) | PK₨1.86b |
| Revenue (TTM) | PK₨26.75b |
16.9x
P/E Ratio1.2x
P/S RatioIs HPL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HPL income statement (TTM) | |
|---|---|
| Revenue | PK₨26.75b |
| Cost of Revenue | PK₨18.32b |
| Gross Profit | PK₨8.43b |
| Other Expenses | PK₨6.57b |
| Earnings | PK₨1.86b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 192.56 |
| Gross Margin | 31.51% |
| Net Profit Margin | 6.94% |
| Debt/Equity Ratio | 17.6% |
How did HPL perform over the long term?
See historical performance and comparisonDividends
4.2%
Current Dividend Yield70%
Payout RatioDoes HPL pay a reliable dividends?
See HPL dividend history and benchmarks| Hoechst Pakistan dividend dates | |
|---|---|
| Ex Dividend Date | Mar 26 2025 |
| Dividend Pay Date | Apr 29 2025 |
| Days until Ex dividend | 2 days |
| Days until Dividend pay date | 36 days |
Does HPL pay a reliable dividends?
See HPL dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/23 08:36 |
| End of Day Share Price | 2025/03/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hoechst Pakistan Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.